<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2(4)</volume><submitter>Keenan T</submitter><pubmed_abstract>A highly efficient, cost-effective, and environmentally friendly protocol is reported for the C5-selective alkylation of hydantoins under phase-transfer catalysis. The reactions are scalable and only require a catalytic amount of tetrabutylammonium bromide (TBAB) to achieve high yields under mild reaction conditions. Moreover, the method is applicable to a wide range of electrophiles, including alkyl-, allyl-, propargyl-, and benzyl halides, as well as acrylates and dibromoalkanes, but also to virtually any hydantoin precursor. We also highlight the potential for an enantioselective adaptation using a chiral phase-transfer catalyst.</pubmed_abstract><journal>ACS organic &amp; inorganic Au</journal><pagination>312-317</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9954259</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Phase-Transfer-Catalyzed Alkylation of Hydantoins.</pubmed_title><pmcid>PMC9954259</pmcid><pubmed_authors>Keenan T</pubmed_authors><pubmed_authors>Jean A</pubmed_authors><pubmed_authors>Arseniyadis S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phase-Transfer-Catalyzed Alkylation of Hydantoins.</name><description>A highly efficient, cost-effective, and environmentally friendly protocol is reported for the C5-selective alkylation of hydantoins under phase-transfer catalysis. The reactions are scalable and only require a catalytic amount of tetrabutylammonium bromide (TBAB) to achieve high yields under mild reaction conditions. Moreover, the method is applicable to a wide range of electrophiles, including alkyl-, allyl-, propargyl-, and benzyl halides, as well as acrylates and dibromoalkanes, but also to virtually any hydantoin precursor. We also highlight the potential for an enantioselective adaptation using a chiral phase-transfer catalyst.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-26T10:20:07.247Z</modification><creation>2025-04-06T13:17:38.46Z</creation></dates><accession>S-EPMC9954259</accession><cross_references><pubmed>36855589</pubmed><doi>10.1021/acsorginorgau.1c00058</doi></cross_references></HashMap>